Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

Cleveland Clinic Taussig Cancer Institute
M

Targetable Mutations in HR+/HER2- mBC

By Cleveland Clinic Taussig Cancer Institute FEATURING Megan Kruse
By Cleveland Clinic Taussig Cancer Institute FEATURING Megan Kruse
386 views
January 24, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam
Breast
23:52
Cleveland Clinic Taussig Cancer Institute

Targetable Mutations in HR+/HER2- mBC

Feat. M. Kruse
02:51
Cleveland Clinic Taussig Cancer Institute

ASTRO 2023 Insights: "Analysis of the PREDICT Study - Impact of…

Feat. C. Shah
09:51
Cleveland Clinic Taussig Cancer Institute

Mitigation of Cytopenia and Diarrhea Associated With Sacituzumab Gov…

Feat. E. Roesch
15:22
Cleveland Clinic Taussig Cancer Institute

Management of Diarrhea in Patients With HER2+ Breast Cancer Treated …

Feat. M. Kruse
30:05
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor Positive Advanced Breast Cancer Case 1: Management …

Feat. J. Abraham, R. Finn, M. Dickler
14:37
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Postive Advanced Breast Cancer Case 2: Patient with…

Feat. J. Abraham
18:34
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Positive Advanced Breast Cancer: Case 3: Treatment …

Feat. J. Abraham, R. Finn, M. Dickler
11:40
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Postive Advanced Breast Cancer Case 4: Patient with…

Feat. J. Abraham, R. Finn, M. Dickler